Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
about
Advances in the treatment of polyarticular juvenile idiopathic arthritisTreatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations.Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.Tofacitinib for the treatment of moderate-to-severe psoriasis.Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib.Novel Oral Therapies for Psoriasis and Psoriatic Arthritis.Tofacitinib for the treatment of psoriasis.Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Filgotinib, a Selective JAK-1 Inhibitor, After Short-Term Treatment of Rheumatoid Arthritis: Results of Two Randomized Phase IIa Trials.Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progressionPemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.Intestinally-restricted Janus Kinase inhibition: a potential approach to maximize the therapeutic index in inflammatory bowel disease therapy.Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.The role of the JAK/STAT signal pathway in rheumatoid arthritis.
P2860
Q27001017-A1E1C437-1EDF-498C-A4BF-73F3622C4DA6Q36300479-EBE45550-C62A-4A5E-84BB-E83F37DCD157Q38260198-773865D1-97EF-44A1-BF29-808DD3C4335FQ38349779-CA8B7E50-8AD6-4108-BD25-CDF13888D405Q38604390-7BD69910-BF33-46C7-BDE4-AC5A317574A0Q38753877-8B4164CC-8716-4B7D-AEDF-BD26D0B15314Q38856883-B07420BE-FD6F-4265-922C-5244BAEE12FAQ40169515-D064A6AF-D1E2-49E6-8B28-D8E493F5E16AQ42039131-EE6B5435-17A2-4F21-AF61-243FD4648CC3Q47219879-C354DAAE-4732-44E0-894E-B1338FE8C00CQ49624659-A6CD15F8-9E3E-4DE5-8F05-36E7D51A42B9Q50910994-08DE1585-FFF9-4696-B28C-DB780959E039Q55487787-457C2EF3-1590-4A7A-8285-22DC915458A9
P2860
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
@ast
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
@en
type
label
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
@ast
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
@en
prefLabel
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
@ast
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
@en
P2093
P1476
Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis.
@en
P2093
Kirandeep Kaur
Sandeep Kaushal
Sonesh Kalra
P304
P356
10.1016/J.CLINTHERA.2014.06.018
P577
2014-07-01T00:00:00Z